Bonesupport Holding AB (publ) (STO:BONEX)
Sweden
· Delayed Price · Currency is SEK 254.20
-0.80 (-0.31%)
May 30, 2025, 5:29 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Cerament Gentamicin and Ceramanent Vancomycin | 358.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Gentamicin and Ceramanent Vancomycin Growth | 219.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Bone Void Filler | 223.09M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Bone Void Filler Growth | 6.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 9.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 52.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| North America | 442.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 104.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 73.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | 51.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Rest of the World | 63.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Rest of the World Growth | 18.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | 11.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | 19.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|